Recall issued for sodium bicarbonate, lidocaine HCl injections due to potential glass contamination

Sodium bicarbonate overview: 

• Who: Hospira Inc. is recalling one lot of its sodium bicarbonate injection, along with two lots of lidocaine HCI injection. 
• Why: The injections are being recalled due to the potential presence of glass particulate matter in the solution.
• Where: The injection recall is effective across the United States and Puerto Rico.

Hospira Inc., a Pfizer company, is recalling one lot of its sodium bicarbonate injection and two lots of its lidocaine HCI injection due to the potential presence of glass particulate matter in the solutions.

The recall covers the following lots:

• 4.2% sodium bicarbonate injection, USP Glass Abboject Syringe, lot GJ5007, with an expiration of Aug. 1, 2024
• 1% lidocaine HCl injection, USP Lifeshield Glass Abboject Syringe, lot 42290DK, with an expiration date of June 1, 2024
• 2% lidocaine HCl injection, USP Lifeshield Glass Abboject Syringe, lot GH6567, with an expiration of July 1, 2024

It is unlikely that a person would have a serious adverse reaction to the particulate, but the particulate could lead to inflammation of a vein, granuloma and blockage of blood vessels or life-threatening blood clot events, according to the lidocaine recall.

Injections should be returned for refund, recall says

Hospira Inc. says it has not received any reports of illness related to the recall so far. The company is not facing legal action over the recall, but Top Class Actions follows recalls closely as they sometimes lead to class action lawsuits.

Pfizer has notified consignees about the process to return the product while hospitals or institutions should contact Sedgwick Inc.

Pfizer can be reached at 1-800-438-1985, option 3, between 8 a.m. and 7 p.m. Eastern, Monday through Friday, or at pfizermedinfo.com. Sedgwick Inc. can be reached at 1-800-805-3093 between 8 a.m. and 5 p.m. Eastern, Monday through Friday.

Late last year, Exela Pharma Sciences recalled 63 lots of its sodium bicarbonate injection, USP, 8.4%, 50 mEq/50 mL vials. 

Are you affected by the sodium bicarbonate recall? Let us know in the comments.

Read About More Class Action Lawsuits & Class Action Settlements:

• Batch of betaxolol tablets recalled over possible oxycodone contamination
• Family Dollar initiates recall for OTC drugs, medical devices shipped outside temp recs
• Biomic Sciences initiates recall for nasal sprays due to microbial contamination
• Tylenol, Mucinex buyer files class action lawsuit over allegedly ineffective ingredient